Skip to main content

Table 3 Performance of three different supervised analyses on validation series

From: Predicting a local recurrence after breast-conserving therapy by gene expression profiling

Analysis WS supervised 70-genes supervised Hypoxia supervised
Sensitivity (percentage) 88 63 75
Specificity (percentage) 74 50 44
Low risk/high riska (percentage) 67/33 49/51 42/58
10-year LC low/high (percentage) 95/71 87/86 87/85
p b 0.0008 0.34 0.4
  1. WS, wound signature; LC, local control.
  2. aIn validation set (percentages; n = 80); b p value in validation set (log-rank).
\